MED

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 115.73 M105.56 M89.41 M75.1 M76.04 M76.38 M 316.93 M Gross profit 84.25 M76.64 M62.16 M52.14 M51.76 M53.4 M 219.45 M Operating expenses 85.89 M77.72 M66.85 M60.31 M55.11 M57.72 M 240 M Selling/general/admin expenses 85.51 M77.71 M66.24 M59.94 M55.05 M57.72 M 238.96 M Research & development —————— — Operating income -1.26 M-1.07 M-4.08 M-7.8 M-3.29 M-4.33 M -19.51 M Non-Operating Income, Total 1.79 M3.94 M1.42 M1.42 M1.35 M1.34 M 5.54 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 1.79 M1.37 M1.43 M1.42 M1.38 M1.35 M 5.57 M Unusual income/expense 487 K2.57 M-2 0001 000-25 K-11 K -37 K Pretax income 526 K2.88 M-2.66 M-6.38 M-1.94 M-2.99 M -13.97 M Equity in earnings —————— — Taxes 1.3 M395 K-396 K11.74 M181 K109 K 11.63 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -772 K2.48 M-2.26 M-18.12 M-2.12 M-3.1 M -25.6 M Discontinued operations —————— — Net income -772 K2.48 M-2.26 M-18.12 M-2.12 M-3.1 M -25.6 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -772 K2.48 M-2.26 M-18.12 M-2.12 M-3.1 M -25.6 M Basic earnings per share (Basic EPS) -0.070.23-0.21-1.65-0.19-0.28 -2.33 Diluted earnings per share (Diluted EPS) -0.070.22-0.21-1.64-0.19-0.28 -2.32 Average basic shares outstanding 10.95 M10.99 M10.99 M10.98 M11.01 M11.13 M — Diluted shares outstanding 10.95 M11.06 M10.99 M10.98 M11.01 M11.13 M — EBITDA 2.4 M2.97 M-1.24 M-4.71 M125 K-881 K -6.7 M EBIT -1.65 M-1.07 M-4.69 M-8.18 M-3.36 M-4.33 M -20.55 M Cost of revenue 31.48 M28.91 M27.25 M22.96 M24.29 M22.99 M 97.48 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 3.28 M4.04 M3.45 M3.46 M3.48 M3.45 M 13.85 M